Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA. Gakis G, et al. Among authors: clayman rh. Ann Oncol. 2015 Aug;26(8):1754-9. doi: 10.1093/annonc/mdv230. Epub 2015 May 12. Ann Oncol. 2015. PMID: 25969370 Free article.
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma.
Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA. Gakis G, et al. Among authors: clayman rh. Urol Oncol. 2018 Jan;36(1):10.e7-10.e14. doi: 10.1016/j.urolonc.2017.09.012. Epub 2017 Oct 18. Urol Oncol. 2018. PMID: 29055518 Free PMC article.
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.
Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. Gakis G, et al. Among authors: clayman rh. World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17. World J Urol. 2016. PMID: 25981402 Free PMC article.
Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM. Gakis G, et al. Among authors: clayman rh. Urol Int. 2016;97(2):134-41. doi: 10.1159/000448335. Epub 2016 Jul 28. Urol Int. 2016. PMID: 27462702 Free PMC article.
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA. Giacalone NJ, et al. Among authors: clayman rh. Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9. Eur Urol. 2017. PMID: 28081860
HIV Infection and Survival Among Women With Cervical Cancer.
Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D, Kebabonye-Pusoentsi M, Clayman R, Mapes AC, Tapela N, Asmelash A, Medhin H, Viswanathan AN, Russell AH, Lin LL, Kayembe MKA, Mmalane M, Randall TC, Chabner B, Lockman S. Dryden-Peterson S, et al. J Clin Oncol. 2016 Nov 1;34(31):3749-3757. doi: 10.1200/JCO.2016.67.9613. J Clin Oncol. 2016. PMID: 27573661 Free PMC article.
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.
Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA. Sanchez A, et al. Among authors: clayman rh. J Urol. 2018 Feb;199(2):407-415. doi: 10.1016/j.juro.2017.08.106. Epub 2017 Sep 1. J Urol. 2018. PMID: 28870862
Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.
Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA. Buscariollo DL, et al. Among authors: clayman rh. Pract Radiat Oncol. 2017 Mar-Apr;7(2):e125-e133. doi: 10.1016/j.prro.2016.10.010. Epub 2016 Oct 19. Pract Radiat Oncol. 2017. PMID: 28274403
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA. Mak KS, et al. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1028-1036. doi: 10.1016/j.ijrobp.2016.08.023. Epub 2016 Aug 24. Int J Radiat Oncol Biol Phys. 2016. PMID: 27727064
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.
Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA. Rodin D, et al. Clin Genitourin Cancer. 2017 Aug 3:S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28864223
13 results